ABSTRACT
Background:
Ocular manifestations of systemic diseases pose significant challenges to clinicians due to their diverse presentations and potential impact on vision. Understanding these manifestations is crucial for effective patient management and prevention of vision loss.
Materials and Methods:
In this prospective clinical study, we investigated ocular manifestations in 50 patients with various systemic diseases, including diabetes mellitus, hypertension, autoimmune disorders, and infectious diseases. Patients underwent comprehensive ocular examinations and systemic evaluations to assess the prevalence and characteristics of ocular complications associated with each systemic condition.
Conclusion:
Diabetic retinopathy was the most common ocular manifestation among diabetic patients, while hypertensive retinopathy predominated in hypertensive individuals. Autoimmune disorders were associated with uveitis and retinal vasculitis, whereas infectious diseases presented with ocular infections. Correlation analyses revealed significant associations between systemic parameters and ocular findings, emphasizing the importance of systemic disease control in preventing vision-threatening complications.
KEYWORDS: Diabetic retinopathy, hypertensive retinopathy, interdisciplinary collaboration, ocular infections, ocular manifestations, retinal vasculitis, systemic diseases, uveitis
INTRODUCTION
Ocular manifestations of systemic diseases represent a complex interplay between systemic pathophysiology and ocular structures, necessitating a multidisciplinary approach for effective management. Conditions such as diabetes mellitus, hypertension, autoimmune disorders, and infectious diseases have been implicated in a spectrum of ocular complications, ranging from mild discomfort to severe vision impairment.[1,2] Understanding the ocular implications of these systemic diseases is imperative for clinicians involved in the care of affected individuals.
Diabetes mellitus, for instance, is associated with various ocular manifestations, including diabetic retinopathy, diabetic macular edema, cataracts, and glaucoma, all of which can lead to significant visual morbidity if left untreated.[3] Similarly, hypertension has been linked to hypertensive retinopathy, characterized by retinal vascular changes such as arteriolar narrowing, arteriovenous nicking, and retinal hemorrhages, which may progress to vision-threatening complications.[4] Autoimmune disorders, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), may manifest ocularly as uveitis, scleritis, or keratitis, necessitating close collaboration between rheumatologists and ophthalmologists for optimal management.[2] In addition, infectious diseases such as herpes simplex virus and cytomegalovirus can cause sight-threatening ocular infections, highlighting the importance of early diagnosis and targeted treatment.[5]
Despite the recognition of these ocular manifestations, there remains a need for further investigation into the prevalence, clinical characteristics, and management strategies of systemic diseases affecting the eye. This study aims to contribute to the existing literature by providing insights into the ocular manifestations of systemic diseases and their implications for comprehensive patient care.
MATERIALS AND METHODS
Study design
This was a prospective clinical study. The study protocol was approved by the institutional review board, and all procedures were performed following the tenets of the Declaration of Helsinki.
Participant selection
Fifty patients with a confirmed diagnosis of systemic diseases, including diabetes mellitus, hypertension, autoimmune disorders, and infectious diseases, were recruited from the outpatient departments of relevant specialties. Informed consent was obtained from all participants prior to enrollment.
Ocular examination
Each participant underwent a comprehensive ocular examination conducted by experienced ophthalmologists. The examination included assessment of visual acuity using Snellen charts, intraocular pressure measurement using applanation tonometry, slit-lamp biomicroscopy for anterior segment evaluation, dilated fundus examination for posterior-segment evaluation, and specialized imaging techniques such as optical coherence tomography and fundus photography when indicated.
Systemic evaluation
Relevant clinical data regarding the systemic disease status, including disease duration, severity, and management, were collected from participants’ medical records. Additional laboratory investigations, including glycated hemoglobin (HbA1c) levels for diabetic patients, blood pressure measurements for hypertensive patients, autoimmune serology for autoimmune disorder patients, and viral polymerase chain reaction tests for infectious disease patients, were performed as appropriate.
Data analysis
Data collected from ocular examinations and systemic evaluations were analyzed descriptively to determine the prevalence and characteristics of ocular manifestations associated with each systemic disease. Statistical analysis was performed using appropriate software, and associations between systemic parameters and ocular findings were explored using correlation analyses.
RESULTS
Fifty patients with systemic diseases were included in the study, comprising a diverse range of conditions, including diabetes Table 1 mellitus (n = 15), hypertension (n = 12), autoimmune disorders (n = 10), and infectious diseases (n = 13).
Table 1.
Demographic characteristics of study participants
| Parameter | Total (n=50) | Diabetes (n=15) | Hypertension (n=12) | Autoimmune (n=10) | Infectious (n=13) |
|---|---|---|---|---|---|
| Age (years, mean±SD) | 54.8±10.3 | 59.2±8.7 | 56.5±11.2 | 48.7±7.9 | 51.4±9.6 |
| Gender (Male/Female) | 27/23 | 8/7 | 6/6 | 5/5 | 8/5 |
Among diabetic patients, diabetic retinopathy was the most common ocular manifestation (80%), followed by hypertensive retinopathy among hypertensive patients (66.7%). Autoimmune disorders were associated with uveitis (40%) and retinal vasculitis (30%), while infectious diseases predominantly presented with ocular infections (46.2%) Table 2.
Table 2.
Ocular manifestations in study participants
| Ocular Manifestation | Diabetes (n=15) | Hypertension (n=12) | Autoimmune (n=10) | Infectious (n=13) |
|---|---|---|---|---|
| Diabetic retinopathy | 12 (80%) | 2 (16.7%) | 0 | 0 |
| Hypertensive retinopathy | 1 (6.7%) | 8 (66.7%) | 0 | 0 |
| Uveitis | 0 | 0 | 4 (40%) | 1 (7.7%) |
| Retinal vasculitis | 0 | 1 (8.3%) | 3 (30%) | 0 |
| Ocular infection | 0 | 0 | 0 | 6 (46.2%) |
The correlation analysis revealed significant associations between systemic parameters and ocular findings, highlighting the importance of systemic disease control in preventing ocular complications Table 3.
Table 3.
Correlation between systemic parameters and ocular findings
| Systemic Parameter | Diabetic Retinopathy | Hypertensive Retinopathy | Uveitis | Retinal Vasculitis | Ocular Infection |
|---|---|---|---|---|---|
| HbA1c levels (Diabetes) | 0.68* | - | - | - | - |
| Blood pressure (Hypertension) | - | 0.72* | - | - | - |
| Autoimmune markers (Autoimmune) | - | - | 0.86* | 0.78* | - |
| Viral PCR (Infectious) | - | - | - | - | 0.94* |
*Correlation is significant at P<0.05
DISCUSSION
The present study provides valuable insights into the ocular manifestations of systemic diseases, shedding light on the diverse spectrum of ocular involvement and emphasizing the importance of comprehensive patient care. Our findings corroborate existing literature on the association between systemic diseases and ocular complications, underscoring the need for vigilant monitoring and interdisciplinary collaboration in managing these conditions.[1,2]
Diabetic retinopathy emerged as a predominant ocular manifestation among diabetic patients, consistent with previous studies demonstrating its high prevalence and significant impact on visual morbidity.[3] The strong correlation observed between HbA1c levels and diabetic retinopathy underscores the importance of glycemic control in mitigating ocular complications in diabetic individuals.[4] Similarly, hypertensive retinopathy was prevalent among hypertensive patients, emphasizing the role of blood pressure management in preserving ocular health and preventing vision loss.[2]
Autoimmune disorders, such as SLE and RA, were associated with uveitis and retinal vasculitis in our study cohort, aligning with established literature highlighting the ocular manifestations of autoimmune diseases.[5,6] The significant correlation between autoimmune markers and ocular findings further emphasizes the systemic nature of these conditions and the importance of immunomodulatory therapies in managing associated ocular inflammation.[7]
Infectious diseases, particularly viral infections, presented with a spectrum of ocular manifestations ranging from conjunctivitis to sight-threatening retinitis, consistent with previous reports on ocular involvement in viral illnesses.[8] The high prevalence of ocular infections in our infectious disease cohort highlights the need for prompt diagnosis and targeted antiviral therapy to prevent irreversible visual impairment.[9]
Interdisciplinary collaboration between ophthalmologists and healthcare providers managing systemic diseases is paramount in ensuring timely detection and management of ocular manifestations. Regular ocular screening, alongside systemic disease monitoring, can facilitate early intervention and prevent progression to vision-threatening complications.[10]
Despite the valuable insights provided by this study, certain limitations should be acknowledged. The sample size was relatively small, limiting the generalizability of findings. In addition, the observational nature of the study precludes establishing causal relationships between systemic parameters and ocular manifestations.
CONCLUSION
In conclusion, our study underscores the intricate relationship between systemic diseases and ocular health, emphasizing the need for a holistic approach to patient care. Future research endeavors should focus on larger cohorts and longitudinal studies to further elucidate the mechanisms underlying ocular manifestations of systemic diseases and optimize therapeutic strategies for improved patient outcomes.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
- 1.Wong TY, Klein R, Islam FMA, Cotch MF, Folsom AR, Klein BEK, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol. 2006;141:446–55. doi: 10.1016/j.ajo.2005.08.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med. 2004;351:2310–7. doi: 10.1056/NEJMra032865. [DOI] [PubMed] [Google Scholar]
- 3.Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124–36. doi: 10.1016/S0140-6736(09)62124-3. [DOI] [PubMed] [Google Scholar]
- 4.Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology. 1984;91:1464–74. doi: 10.1016/s0161-6420(84)34102-1. [DOI] [PubMed] [Google Scholar]
- 5.Jabs DA, Nussenblatt RB, Rosenbaum JT Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–16. doi: 10.1016/j.ajo.2005.03.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Sivaraj RR, Durrani OM, Denniston AK, Murray PI, Gordon C. Ocular manifestations of systemic lupus erythematosus. Rheumatology. 2007;46:1757–62. doi: 10.1093/rheumatology/kem173. [DOI] [PubMed] [Google Scholar]
- 7.Sen HN, Vitale S, Gangaputra SS, Nusssenblatt RB, Liesegang TL, Levy-Clarke GA, et al. Periocular corticosteroid injections in uveitis: Effects and complications. Ophthalmology. 2014;121:2275–86. doi: 10.1016/j.ophtha.2014.05.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea. 2001;20:1–13. doi: 10.1097/00003226-200101000-00001. [DOI] [PubMed] [Google Scholar]
- 9.Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol. 2002;134:102–14. doi: 10.1016/s0002-9394(02)01526-x. [DOI] [PubMed] [Google Scholar]
- 10.Scanlon PH, Aldington SJ, Leal J, Luengo-Fernandez R, Oke J, Sivaprasad S, et al. Development of a cost-effective telemedicine-based eye screening programme for diabetic retinopathy. J Diabetes Sci Technol. 2014;8:256–67. [Google Scholar]
